National Health Investors INC Form 4 insider transactions

National Health Investors Director Candice W. Todd exercised stock options and increased her direct beneficial ownership of common stock by 1,295 shares.

National Health Investors' Chief Investment Officer, Kevin Carlton Pascoe, exercised stock options and adjusted his common stock holdings.

National Health Investors' SVP/Chief Transaction Officer, Kristin Sallee Gaines, exercised stock options and subsequently sold a portion of her common stock holdings.

National Health Investors Director Robert G. Adams exercised stock options and adjusted his beneficial ownership of common stock.

National Health Investors CFO John L. Spaid exercised stock options and sold shares for tax purposes, adjusting his direct beneficial ownership.

A director at National Health Investors Inc. exercised stock options and sold shares for tax withholding purposes in a pre-planned transaction.

National Health Investors CEO D. Eric Mendelsohn exercised stock options and adjusted his direct beneficial ownership of common stock, increasing his net holdings by 16,372 shares.

National Health Investors Director Charlotte A. Swafford exercised multiple stock options and increased her indirect beneficial ownership of common stock.

National Health Investors Director James R. Jobe exercised stock options and adjusted his common stock holdings, increasing direct ownership.

National Health Investors SVP/Chief Accounting Officer David L. Travis exercised stock options and subsequently disposed of shares for tax purposes.

Robert Chapin, a director of National Health Investors, Inc., acquired 10,000 stock options on May 8, 2025.

CFO John L. Spaid of National Health Investors Inc. reports the disposal of 259 shares of common stock to cover tax obligations upon vesting.

D. Eric Mendelsohn, CEO and President of National Health Investors, reports the disposition of 394 shares of common stock to cover tax obligations upon vesting.

Director Robert G. Adams of National Health Investors Inc. reports exercising stock options and disposing of shares, resulting in changes to his beneficial ownership.

D. Eric Mendelsohn, CEO and President of National Health Investors, reports acquisition of shares and stock options.

Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc., reports acquisition of common stock and stock options.

Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors, reports acquisition of common stock and stock options.

David L. Travis, SVP/Chief Accounting Officer of National Health Investors, acquired 5,500 shares of common stock and multiple tranches of stock options.

John L. Spaid, CFO of National Health Investors, reports acquisition of common stock and stock options.

Candice W. Todd, a director of National Health Investors Inc., reported the acquisition of 10,000 stock options on March 3, 2025.

Director Charlotte A. Swafford reports acquisition of stock options and updates to beneficial ownership in National Health Investors Inc.

Director Robert A. McCabe Jr. reports acquisition of shares through dividend reinvestment and stock options in National Health Investors Inc.

Director James R. Jobe reports transactions in National Health Investors Inc. stock, including the acquisition of stock options.

Director Tracy M J Colden acquired 10,000 stock options in National Health Investors Inc. on March 3, 2025.

Director Robert G. Adams reports changes in beneficial ownership of National Health Investors Inc. stock and stock options.

D. Eric Mendelsohn, CEO and President of National Health Investors, reports the disposition of shares for tax settlement and ongoing stock option holdings.

CFO John L. Spaid of National Health Investors Inc. reports the disposition of 267 shares of common stock for tax settlement purposes on February 23, 2025.

Director W. Andrew Adams distributed 12,635 shares of National Health Investors Inc (NHI) common stock from the JMA Grandchildren's Trust to its beneficiaries as part of estate planning on September 27, 2024.

Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on September 25, 2024.

David L. Travis, SVP/Chief Accounting Officer of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on September 18, 2024.